Holen Sie sich die Stockscreener-App
7.45
0.07%
0.005
Handel nachbörslich:
7.45
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AVXL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$7.445
Offen:
$7.59
24-Stunden-Volumen:
1.44M
Relative Volume:
1.56
Marktkapitalisierung:
$630.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-43.16M
KGV:
-11.29
EPS:
-0.66
Netto-Cashflow:
$-29.31M
1W Leistung:
-18.58%
1M Leistung:
+31.86%
6M Leistung:
+63.74%
1J Leistung:
+18.82%
1-Tages-Spanne:
$7.18
$7.60
1-Wochen-Bereich:
$7.18
$9.5975
52-Wochen-Spanne:
$3.25
$10.45
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Firmenname
Anavex Life Sciences Corporation
Sektor
Branche
Telefon
844-689-3939
Adresse
630 5TH AVENUE, NEW YORK
Vergleichen Sie AVXL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| AVXL | 7.45 | 630.58M | 0 | -43.16M | -29.31M | -0.66 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Eingeleitet | Berenberg | Buy |
| 2021-09-23 | Eingeleitet | BTIG Research | Buy |
| 2020-12-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-28 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-02-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Eingeleitet | Janney | Buy |
| 2018-05-16 | Fortgesetzt | Maxim Group | Buy |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-13 | Bestätigt | Maxim Group | Buy |
| 2017-09-29 | Fortgesetzt | Noble Financial | Buy |
| 2017-02-07 | Eingeleitet | Noble Financial | Buy |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
Alle ansehen
Anavex Life Sciences Corporation Aktie (AVXL) Neueste Nachrichten
Contrasting Palisade Bio (NASDAQ:PALI) & Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Reaches New 52-Week HighShould You Buy? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Shares Up 8.1%Here's Why - MarketBeat
Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla? - Benzinga
Anavex Life Sciences: Weighing The Pros And Cons Of A Possible EU Approval Scenario - Seeking Alpha
HC Wainwright Reiterates "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Loss-Making Anavex Life Sciences Corp. (NASDAQ:AVXL) Expected To Breakeven In The Medium-Term - Simply Wall St
Anavex's Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer's Trial: Data Presented at CTAD Conference 2024 - The Manila Times
NY Biopharma Shares Promising Clinical Data - Streetwise Reports
Anavex Life Sciences (NASDAQ:AVXL) Rating Reiterated by HC Wainwright - MarketBeat
Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia - StockTitan
Short Interest in Anavex Life Sciences Corp. (NASDAQ:AVXL) Declines By 10.3% - MarketBeat
Examining Anavex Life Sciences Corporation (AVXL) stock is warranted - US Post News
Anavex Life Sciences Corp (AVXL) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... - Yahoo Finance
Market Insights: Anavex Life Sciences Corporation (AVXL)’s Notable Drop of -2.42, Closing at 5.24 - The Dwinnex
Understanding the Risks of Investing in Anavex Life Sciences Corporation (AVXL) - Knox Daily
Anavex Stock: A Risky Bet On CNS Drug Development (Rating Downgrade) (NASDAQ:AVXL) - Seeking Alpha
The time has not yet come to remove your chips from the table: Anavex Life Sciences Corporation (AVXL) - SETE News
Renaissance Technologies LLC Has $1.97 Million Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - MarketBeat
A stock that deserves closer examination: Anavex Life Sciences Corporation (AVXL) - US Post News
Anavex Life Sciences Corporation (AVXL) may enjoy gains as insiders got busy in the recent days - Knox Daily
Anavex Life Sciences Corporation [AVXL] Director makes an insider acquire of 2,835 shares worth 10,319. - Knox Daily
Australian Vanadium gets interest for $31 million finance support - Mining.com.au
AVXL Shares Experience Surge in Value - Knox Daily
Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near? - Yahoo Finance
Australian Vanadium receives Letter of Interest for US$31 million in debt financing from EXIM - Proactive Investors UK
Ratios Revealed: Decoding Anavex Life Sciences Corporation (AVXL)’s Financial Health - The Dwinnex
Oops! Disney May Have Just Spoiled their Next Marvel Series - Bleeding Fool
A better buy-in window may exist right now for Anavex Life Sciences Corporation (AVXL) - SETE News
Alzheimer's Drugs Market Report Details Size, Share, Demand, Forecast, Trends To 2033 - WhaTech
AVXL’s Market Balancing Act: Weighing Gains and Losses in 2023 - The InvestChronicle
Investing in Anavex Life Sciences Corporation (AVXL) might be a great opportunity, but the stock is a bit overvalued - US Post News
Anavex Life Sciences Corporation (AVXL) receives a Neutral rating from Cantor Fitzgerald - Knox Daily
Market Recap: Anavex Life Sciences Corporation (AVXL)’s Positive Momentum, Closing at 5.21 - The Dwinnex
AVXL Stock Sees Decline of Approximately -8.72% in Last Five Days - Knox Daily
Investors in cash trouble should check out Anavex Life Sciences Corporation (AVXL) - SETE News
Ratios Reveal: Breaking Down Anavex Life Sciences Corporation (AVXL)’s Financial Health - The Dwinnex
Investing in Anavex Life Sciences Corporation (AVXL): What You Must Know - Knox Daily
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire Inc.
A History of Outperforming Analyst Forecasts and Beating the Odds: Anavex Life Sciences Corporation (AVXL) - SETE News
Recent Insider Activity Could Benefit Anavex Life Sciences Corporation (AVXL) - Knox Daily
Market Watch Highlights: Anavex Life Sciences Corporation (AVXL) Ends on an Upturn Note at 6.02 - The Dwinnex
Should investors be concerned about Anavex Life Sciences Corporation (AVXL)? - US Post News
Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024 - StockTitan
Anavex Life Sciences Corporation (AVXL) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Anavex Life Sciences Corporation [NASDAQ: AVXL] Sees Increase in Stock Value - Knox Daily
Was anything positive for Anavex Life Sciences Corporation (AVXL) stock last session? - US Post News
Market Recap Check: Anavex Life Sciences Corporation (AVXL)’s Positive Finish at 6.36, Up/Down 0.63 - The Dwinnex
AVXL (Anavex Life Sciences Corporation) may reap gains as insiders became active recently - Knox Daily
NASDAQ: AVXL Lawsuit Update: Investors Who Lost Money With Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) Should Contact the Shareholders Foundation - AccessWire
Anavex Life Sciences Corporation (AVXL)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Finanzdaten der Anavex Life Sciences Corporation-Aktie (AVXL)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):